Agilent Technologies Inc (A)
Healthcare
Diagnostics & Research
138.40 $
Closing price · As of: 31. Jul 2026
Who owns Agilent Technologies Inc (A)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.7% of the shares are freely tradable; institutional investors hold 94.1%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
94.1%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
99.7%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
2.3%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
282Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Group Inc | 12.08 | 34,105,783 | +0.2 | 12/31/2025 |
| BlackRock Inc | 9.17 | 25,902,662 | +0.1 | 03/31/2026 |
| Vanguard Capital Management, LLC | 6.51 | 18,381,030 | +0.0 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 5.08 | 14,352,682 | +0.0 | 03/31/2026 |
| State Street Corp | 4.52 | 12,764,632 | +0.7 | 03/31/2026 |
| Massachusetts Financial Services Company | 4.47 | 12,624,090 | -10.8 | 03/31/2026 |
| T. Rowe Price Investment Management,Inc. | 3.18 | 8,992,649 | -33.2 | 03/31/2026 |
| Geode Capital Management, LLC | 2.66 | 7,522,028 | +1.3 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 3.19 | 9,006,067 | +0.2 | 04/30/2026 |
| Vanguard 500 Index Investor | 2.60 | 7,334,415 | +1.8 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.